CIK: 0002011385 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 10, 2026
Total Value ($000): $310,538 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | 1,429,014 (+22.4%) | $23,707 (+72.6%) | 7.6% | $11.27 | +26.7% | COM | 71722W107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 7,903,838 (-11.2%) | $286,830 (-15.0%) | 92.4% | $7.96 | +403.9% | COM | 603170101 |